NCT04414189View on ClinicalTrials.gov

Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 7, 2020

Primary Completion Date

July 21, 2021

Study Completion Date

October 19, 2021

Conditions
Sepsis
Interventions
DIAGNOSTIC_TEST

HostDx Sepsis

Blood collection for mRNA analysis

Trial Locations (1)

32610

University of Florida College of Medicine, Gainesville

Sponsors

Lead Sponsor

Inflammatix
All Listed Sponsors
collaborator

University of Florida

OTHER

lead

Inflammatix

INDUSTRY